Avasimibe inhibits tumor growth by targeting FoxM1-AKR1C1 in osteosarcoma
Liang Wang,1 Yang Liu,1 Guanzhen Yu2 1Department of Orthopedic, Changzheng Hospital, Shanghai 200003, China; 2Department of Oncology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China Background: Osteosarcoma (OS) is a rare bone tumor with a...
Main Authors: | Wang L, Liu Y, Yu G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/avasimibe-inhibits-tumor-growth-by-targeting-foxm1-akr1c1-in-osteosarc-peer-reviewed-article-OTT |
Similar Items
-
Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
by: Yunshu Gao, et al.
Published: (2021-05-01) -
Effect of abnormal MZF1 and FoxM1 expression on cell proliferation and apoptosis in osteosarcoma
by: Lin Liu, et al.
Published: (2018-04-01) -
Correlation of the abnormal FoxM1 and Sox9 expression in osteosarcoma with the pathologic features of tumor
by: Yi-Long Peng, et al.
Published: (2018-07-01) -
FoxM1 is Upregulated in Osteosarcoma and Inhibition of FoxM1 Decreases Osteosarcoma Cell Proliferation, Migration, and Invasion
by: Zhu X, et al.
Published: (2020-10-01) -
OPN Induces FoxM1 Expression and Localization through ERK 1/2, AKT, and p38 Signaling Pathway in HEC-1A Cells
by: Yunpeng Xie, et al.
Published: (2014-12-01)